Author(s): Nicholas van As, M.D., Clare Griffin, M.Sc., Alison Tree, M.D., Jaymini Patel, Ph.D., Peter Ostler, F.R.C.R., Hans van der Voet, M.D., Andrew Loblaw, M.D., William Chu, M.D., Daniel Ford, F.R.C.R., Shaun Tolan, M.B., B.Ch., Suneil Jain, Ph.D. https://orcid.org/0000-0001-7429-4791, Philip Camilleri, F.R.C.R., Kiran Kancherla, F.R.C.R., John Frew, F.R.C.R., Andrew Chan, F.R.C.R., Olivia Naismith, M.Sc., John Armstrong, F.F.R.R.C.S.I., John Staffurth, M.D., Alexander Martin, M.D., Ian Dayes, M.D., Paula Wells, Ph.D., Derek Price, Emily Williamson, M.Sc., Julia Pugh, C.I.M.Dip., Georgina Manning, B.A., Stephanie Brown, Ph.D., Stephanie Burnett, B.Sc., and Emma Hall, Ph.D.
Author Affiliations
From the Royal Marsden Hospital (N.A., A.T., O.N.), the Institute of Cancer Research (N.A., C.G., A.T., J. Patel, E.W., J. Pugh, G.M., S. Brown, S. Burnett, E.H.), St. Bartholomew’s Hospital (P.W.), and Patient and Public Representative (D.P.), London, the Mount Vernon Cancer Centre, Northwood (P.O.), the James Cook University Hospital, Middlesbrough (H.V.), University Hospitals Birmingham, Birmingham (D.F.), the Clatterbridge Cancer Centre, Birkenhead (S.T.), Queen’s University Belfast, Belfast (S.J.), Churchill Hospital, Oxford (P.C.), University Hospitals of Leicester, Leicester (K.K.), Freeman Hospital, Newcastle (J.F.), University Hospitals Coventry and Warwickshire, Coventry (A.C.), Velindre Cancer Centre, Cardiff (J.S.), and Cambridge University Hospitals NHS Foundation Trust, Cambridge (A.M.) — all in the United Kingdom; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto (A.L., W.C.), and the Department of Oncology, McMaster University, Hamilton, ON (I.D.) — both in Canada; and Cancer Trials Ireland and St. Luke’s Radiation Oncology